Intézmény

Hospital de São João

Porto, PortugáliaHonlap

Más néven: Centro Hospitalar de São João · Hospital of St. John · CHSJ

17futó vizsgálat
14lezárt vizsgálat
17 318publikáció (OpenAlex)

Futó vizsgálatok

Még nem toboroz
Prevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility Mixed-Methods Study
NCT07772544· Sociedade Portuguesa de Reumatologia· Forrás
Toboroz
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
NCT07589634· 2. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
NCT07213674· 3. fázis· Amgen· Forrás
Toboroz
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459· 3. fázis· Amgen· Forrás
Toboroz
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT06852222· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
NCT06571149· 4. fázis· Insel Gruppe AG, University Hospital Bern· Forrás
Fut, nem toboroz
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
NCT06680817· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)
NCT05797740· Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany· Forrás
Fut, nem toboroz
The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)
NCT06416644· Hospital do Divino Espírito Santo de Ponta Delgada· Forrás
Toboroz
European Myeloma Network (EMN) Sample Project
NCT06237803· European Myeloma Network B.V.· Forrás
Toboroz
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
NCT05219617· 3. fázis· SK Life Science, Inc.· Forrás
Fut, nem toboroz
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT05160584· Janssen Pharmaceutica N.V., Belgium· Forrás
Toboroz
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
NCT04822181· 3. fázis· Novo Nordisk A/S· Forrás
Toboroz
LANDMARK Trial: a Randomised Controlled Trial of Myval THV
NCT04275726· Meril Life Sciences Pvt. Ltd.· Forrás
Fut, nem toboroz
Development of Novel Clinical Endpoints in Intermediate AMD
NCT03349801· Frank G. Holz· Forrás
Toboroz
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
NCT02979119· PedNet Haemophilia Research Foundation· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Lezárt vizsgálatok

Visszavonták
A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
NCT05126966· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
NCT05649137· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)
NCT05646706· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
NCT05514535· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors
NCT05053139· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)
NCT05033080· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Lezárult
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
NCT04777201· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
NCT04129502· 3. fázis· Takeda· Forrás
Lezárult
Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)
NCT04934800· Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany· Forrás
Lezárult
Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
NCT03529045· LivaNova· Forrás
Lezárult
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535· 3. fázis· Alfasigma S.p.A.· Forrás
Lezárult
Avelumab in First-line NSCLC (JAVELIN Lung 100)
NCT02576574· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás
Lezárult
Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses
NCT02467270· 2. fázis· Takeda· Forrás
Lezárult
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
NCT02078427· Baxalta now part of Shire· Forrás

Regiszterbeli névváltozatok (18)

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

Centro Hospitalar de São João, E.P.E.
Porto, 4200-319
5 vizsgálat
ULS De São João, E.P.E. - Hospital de São João
Porto, 4200-319
4 vizsgálat
Hospital de Sao Joao
Porto, 4200-319
3 vizsgálat
Uls Sao Joao - Hosp. Sao Joao
Porto, 4200 319
3 vizsgálat
Centro Hospitalar de São João
Porto, 4200-319
2 vizsgálat
- NCT04275726LANDMARK Trial: a Randomised Controlled Trial of Myval THV
  Contact: Dr. Joao Carlos Silva, PhD
- NCT03529045Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
Centro Hospitalar de Sao Joao, EPE
Porto, Porto District 4200 319
2 vizsgálat
- NCT05219617Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
  Contact: Raquel Sousa, MD (principal investigator)
- NCT02914535Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Centro Hospitalar Sao Joao
Porto, 4200-319
2 vizsgálat
- NCT06416644The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)
- NCT02467270Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses
Unidade Local de Saude de Sao Joao, EPE - Hospital de Sao Joao
Porto, 4200-319
2 vizsgálat
- NCT07213674A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- NCT07037459Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Centro Hospitalar de São João, E.P.E. - Serviço de Neurologia
Porto
1 vizsgálat
- NCT04934800Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)
Centro Hospitalar de Sao Joao - Hospital de Sao Joao
Porto, 4200-319
1 vizsgálat
- NCT04844606A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
  Contact: Eunice Trindade (principal investigator)
Centro Hospitalar de São João_Porto
Porto, 4200-319
1 vizsgálat
- NCT05053139A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors
Centro Hospitalar São João, S. Imuno-hemoterapia
Porto
1 vizsgálat
- NCT02979119The European Paediatric Network for Haemophilia Management ( PedNet Registry)
  Contact: Manuela Carvalho, MD
Chsj - Hosp. Sao Joao
Porto
1 vizsgálat
- NCT06237803European Myeloma Network (EMN) Sample Project
  Contact: Bergantim (principal investigator)
Hospital de Sao Joao; Servico de Oftalmologia
Porto, 4200-319
1 vizsgálat
- NCT05126966A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
Hospital Sao Joao
Porto
1 vizsgálat
- NCT05033080A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)
Unidade Local de Saúde de São João, Serviço de Reumatologia, Hospital São João
Porto
1 vizsgálat
- NCT07772544Prevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility Mixed-Methods Study
  Contact: Alexandra Bernardo, MD
Centro Hospitalar de Sao Joao, EPE /ID# 152871
Porto, 4200-319
Unidade Local de Saúde de São João E.P.E. - Hospital São João - Serviço de Pediatria
Porto, 4200-319

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Hipertrófiás kardiomiopátia13 munka · 0 vizsgálat
Myocarditis12 munka · 0 vizsgálat
Policisztás vesebetegség4 munka · 0 vizsgálat
Iron deficiency anaemia4 munka · 0 vizsgálat
Fabry-betegség3 munka · 0 vizsgálat
Testicular cancer3 munka · 0 vizsgálat

Intézményadatok: ROR 04qsnc772 (CC0-1.0)Frissítve: 2026. nov. 14.

Hibát jelzek